New and emerging therapies for diabetic kidney disease

Ricardo Correa-Rotter^{1

2}, Louise J Maple-Brown^{3

4}, Rakesh Sahay⁵, Katherine R Tuttle^{6

7}, Ifeoma I Ulasi^{8

9

10}

Affiliations

¹ Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. correarotter@gmail.com.
² Universidad Nacional Autónoma de México, Mexico City, Mexico. correarotter@gmail.com.
³ Menzies School of Health Research, Charles Darwin University, Darwin, Australia. louise.maple-brown@menzies.edu.au.
⁴ Department of Endocrinology, Royal Darwin and Palmerston Hospitals, NT Health, Darwin, Australia. louise.maple-brown@menzies.edu.au.
⁵ Osmania Medical College, Hyderabad, India. sahayrk@gmail.com.
⁶ Providence Medical Research Center, Providence Inland Northwest Health, Spokane, WA, USA. katherine.tuttle@providence.org.
⁷ Kidney Research Institute and Institute of Translational Health Sciences, University of Washington, Seattle, WA, USA. katherine.tuttle@providence.org.
⁸ Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Enugu State, Nigeria. ifeomaulasi@yahoo.co.uk.
⁹ Renal Unit, Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Enugu State, Nigeria. ifeomaulasi@yahoo.co.uk.
¹⁰ Renal Unit, Department of Internal Medicine, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria. ifeomaulasi@yahoo.co.uk.

Ricardo Correa-Rotter et al. Nat Rev Nephrol. 2024 Mar.

. 2024 Mar;20(3):156-160.

doi: 10.1038/s41581-023-00782-1. Epub 2024 Jan 2.

Ricardo Correa-Rotter^{1

2}, Louise J Maple-Brown^{3

4}, Rakesh Sahay⁵, Katherine R Tuttle^{6

7}, Ifeoma I Ulasi^{8

9

10}

¹ Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. correarotter@gmail.com.
² Universidad Nacional Autónoma de México, Mexico City, Mexico. correarotter@gmail.com.
³ Menzies School of Health Research, Charles Darwin University, Darwin, Australia. louise.maple-brown@menzies.edu.au.
⁴ Department of Endocrinology, Royal Darwin and Palmerston Hospitals, NT Health, Darwin, Australia. louise.maple-brown@menzies.edu.au.
⁵ Osmania Medical College, Hyderabad, India. sahayrk@gmail.com.
⁶ Providence Medical Research Center, Providence Inland Northwest Health, Spokane, WA, USA. katherine.tuttle@providence.org.
⁷ Kidney Research Institute and Institute of Translational Health Sciences, University of Washington, Seattle, WA, USA. katherine.tuttle@providence.org.
⁸ Department of Medicine, College of Medicine, University of Nigeria, Ituku-Ozalla, Enugu, Enugu State, Nigeria. ifeomaulasi@yahoo.co.uk.
⁹ Renal Unit, Department of Medicine, University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu, Enugu State, Nigeria. ifeomaulasi@yahoo.co.uk.
¹⁰ Renal Unit, Department of Internal Medicine, Alex Ekwueme Federal University Teaching Hospital, Abakaliki, Ebonyi State, Nigeria. ifeomaulasi@yahoo.co.uk.

No abstract available

References

1. Gheith, O. et al. Diabetic kidney disease: worldwide difference of prevalence and risk factors. J. Nephropharmacol 5, 49–56 (2016). - PubMed
1. Shah, V. N. & Mohan, V. Diabetes in India: what is different? Curr. Opin. Endocrinol. Diabetes Obes. 22, 283–289 (2015). - DOI - PubMed
1. Barbour, S. J., Er, L., Djurdjev, O., Karim, M. & Levin, A. Differences in progression of CKD and mortality amongst Caucasian, oriental Asian and South Asian CKD patients. Nephrol. Dial. Transplant. 25, 3663–3672 (2010). - DOI - PubMed
1. Viswanathan, V. & Mirshad, R. The burden of diabetic nephropathy in India: need for prevention. Diabet. Nephrop. 3, 25–28 (2023). - DOI
1. Makkar, B. M. et al. RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2022. Int. J. Diabetes Dev. Ctries. 42, 1–143 (2022). - DOI - PubMed